Cargando…

Spontaneous remission of fully symptomatic visceral leishmaniasis

BACKGROUND: Visceral leishmaniasis (VL), i.e., infection with Leishmania sp. associated with high fever, weight loss, massive splenomegaly and markedly altered laboratory parameters, is generally fatal if untreated. The possibility of transient spontaneous remission of fully symptomatic visceral lei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mouri, Oussama, Benhamou, Mathilde, Leroux, Gaëlle, Chartrel, Nathalie, Devidas, Alain, Thellier, Marc, Amoura, Zahir, Costedoat-Chalumeau, Nathalie, Buffet, Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619209/ https://www.ncbi.nlm.nih.gov/pubmed/26499862 http://dx.doi.org/10.1186/s12879-015-1191-6

Ejemplares similares

Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options
por: Costedoat-Chalumeau, Nathalie, et al.
Publicado: (2005)

Easy Identification of Leishmania Species by Mass Spectrometry
por: Mouri, Oussama, et al.
Publicado: (2014)

Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
por: Morizot, Gloria, et al.
Publicado: (2016)

Commentary: First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry)
por: Costedoat-Chalumeau, Nathalie, et al.
Publicado: (2020)

Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome
por: Bermas, Bonnie, et al.
Publicado: (2022)

Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers
por: Mouri, Oussama, et al.
Publicado: (2023)

Malignant catatonia due to anti-NMDA-receptor encephalitis in a 17-year-old girl: case report
por: Consoli, Angèle, et al.
Publicado: (2011)

Role of asymptomatic and symptomatic humans as reservoirs of visceral leishmaniasis in a Mediterranean context
por: Molina, Ricardo, et al.
Publicado: (2020)

Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)

Transmission potential, skin inflammatory response, and parasitism of symptomatic and asymptomatic dogs with visceral leishmaniasis
por: Verçosa, BLA, et al.
Publicado: (2008)

Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study
por: Chakravarty, Jaya, et al.
Publicado: (2019)

Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers
por: Das, Vidya Nand Rabi, et al.
Publicado: (2020)

Congenital Visceral Leishmaniasis
por: Boehme, Catharina C., et al.
Publicado: (2006)

Immunity to Visceral Leishmaniasis
por: Ali, Nahid, et al.
Publicado: (2012)

Treatment of Visceral Leishmaniasis
por: Moore, E M, et al.
Publicado: (2010)

Immunobiology of visceral leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2012)

Epidemiology of visceral leishmaniasis
por: Ready, Paul D
Publicado: (2014)

SLE-DAS in the First Trimester of Gestation Predicts Maternal Lupus Flares Later in Pregnancy
por: Larosa, Maddalena, et al.
Publicado: (2021)

Epidemiologic Trends in Malaria Incidence Among Travelers Returning to Metropolitan France, 1996-2016
por: Kendjo, Eric, et al.
Publicado: (2019)

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
por: Mondal, Dinesh, et al.
Publicado: (2019)

Visceral Leishmaniasis Treatment, Italy
por: Gradoni, Luigi, et al.
Publicado: (2003)

The reemergence of visceral leishmaniasis in Brazil.
por: Arias, J R, et al.
Publicado: (1996)

Drug Resistance in Visceral Leishmaniasis
por: Maltezou, Helena C.
Publicado: (2010)

Is visceral leishmaniasis a sepsis or not?
por: Puca, E, et al.
Publicado: (2012)

Epidemiology of Visceral Leishmaniasis in Georgia
por: Babuadze, Giorgi, et al.
Publicado: (2014)

Therapeutic Options for Visceral Leishmaniasis
por: Monge-Maillo, Begoña, et al.
Publicado: (2013)

Visceral leishmaniasis with Roth spots
por: Meena, Jagdish, et al.
Publicado: (2014)

Epidemiology of visceral leishmaniasis in Georgia
por: Kokaia, Nora, et al.
Publicado: (2017)

The kinetoplast in the diagnosis of visceral leishmaniasis
por: Murray, Henry W.
Publicado: (2022)

Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus: the French GR2 study
por: Larosa, Maddalena, et al.
Publicado: (2022)

Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients
por: Adriaensen, Wim, et al.
Publicado: (2018)

Leishmania ITS1 Is Genetically Divergent in Asymptomatic and Symptomatic Visceral Leishmaniasis: Results of a Study in Southern Iran
por: Rezaei, Zahra, et al.
Publicado: (2020)

Symptomatic Management of Fever in Children: A National Survey of Healthcare Professionals’ Practices in France
por: Bertille, Nathalie, et al.
Publicado: (2015)

Development and validation of a clinical HPLC method for the quantification of hydroxychloroquine and its metabolites in whole blood
por: Qu, Ying, et al.
Publicado: (2015)

Visceral leishmaniasis (kala-azar) and pregnancy.
por: Figueiró-Filho, Ernesto Antonio, et al.
Publicado: (2004)

Asymptomatic Visceral Leishmaniasis, Northern Israel
por: Adini, Irit, et al.
Publicado: (2003)

Development of Vaccines against Visceral Leishmaniasis
por: Evans, Krystal J., et al.
Publicado: (2012)

Epistaxis in Visceral Leishmaniasis with Hematological Correlation
por: Sigdel, B., et al.
Publicado: (2012)

Cytokines and Their STATs in Cutaneous and Visceral Leishmaniasis
por: Cummings, Hannah E., et al.
Publicado: (2010)

Genetically Modified Organisms and Visceral Leishmaniasis
por: Chhajer, Rudra, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0gs3n35bq6rt3jhh9mvn791vkq